NovaBridge Biosciences
Price
FilingsNewest: 6-K, Report of a foreign issuerSep 8 →Insiders1 insider bought $577,300 in 1 open-market buy. 3 insiders sold $61,956, 0 of 3 sales on a 10b5-1 plan.→HoldersHHLR $11.7MMorgan Stanley $7.1MAihc $5.6M→Financing →
From the filings
Figures
- Net income
- −$46.3Mlast 12 months
- Operating cash flow
- −$20.6Mlast 12 months
- Cash and equivalents
- $210.6Mat the last balance sheet